IE 11 is not supported. For an optimal experience visit our site on another browser.

The FDA has approved the first Alzheimer’s treatment in almost 20 years. It’s “the first, not the last”


The FDA went against an external advisory board and approved Biogen’s Aduhelm drug, the first treatment for Alzheimer’s in almost 20 years. Despite its possible high cost and what opponents are claiming is a lack of evidence about Aduhelm’s efficacy, UsAgainstAlzheimer’s chairman George Vradenburg argues that the drug is necessary to finally help those with Alzheimer’s lead a normal life.